Current Problems in Cardiology
Volume 34, Issue 10 , Pages 483-530 , October 2009

Patent Foramen Ovale, Systemic Embolization, and Closure

References 

  1. Zahn FW. Thrombose de plusieurs branches de la veine cave inferieure avec embolies consecutives das les arteres pulmonair, splenique, renale et iliaque droite. Rev Med Suisse Rom. 1881;1:227–237
  2. Falk V, Walther T, Krankenberg H, et al. Trapped thrombus in a patent foramen ovale. J Thorac Cardiovasc Surg. 1997;45:90–92
  3. Fabricius AM, Kruger M, Hanke M, et al. Caught in the act: Impending paradoxical embolism. Asian Cardiovasc Thorac Ann. 2002;10:342–343
  4. Maroto LC, Molina L, Carrascal Y, et al. Intracardiac thrombus trapped in a patent foramen ovale. Eur J Cardio Thorac Surg. 1997;12:807–810
  5. Hanley PC, Tajik AJ, Hynes JK, et al. Diagnosis and classification of atrial septal aneurysm by two-dimensional echocardiography: report of 80 consecutive cases. J Am Coll Cardiol. 1985;6:1370–1382
  6. Gupta V, Yesilbursa D, Huang WY, et al. Patent foramen ovale in a large population of ischemic stroke patients: diagnosis, age, distribution, gender and race. Echocardiography. 2008;25:217–227
  7. Belvis R, Leta RG, Marti-Fabregas J, et al. Almost perfect concordance between simultaneous transcranial Doppler and transesophageal echocardiography in the quantification of right to left shunts. J Neuroimaging. 2006;16:133–138
  8. Spencer MP, Moehring MA, Jesurum J, et al. Power m-mode transcranial Doppler for diagnosis of patent foramen ovale and assessing transcatheter closure. J Neuroimaging. 2004;14:342–349
  9. Del Sette M, Dinia L, Rizzi D, et al. Diagnosis of right to left shunt with transcranial Doppler and vertebrobasilar recording. Stroke. 2007;38:2254–2256
  10. Liboni W, Molinari F, Allais GB, et al. Patent foramen ovale detected by near-infrared spectroscopy in patients suffering from migraine with aura. Neurol Sci. 2008;29:5182–5185
  11. Mohrs OK, Petersen SE, Erkapic D, et al. Dynamic contrast enhanced MRI before and after transcatheter occlusion of patent foramen ovale. AJR Am J Roentgenol. 2006;188:844–849
  12. Nusser T, Hoher M, Merkle N, et al. Cardiac magnetic resonance imaging and transesophageal echocardiography in patients with transcatheter closure of patent foramen ovale. J Am Coll Cardiol. 2006;48:322–329
  13. Ditullio MR, Sacco RL, Sciacca RR, et al. Patent foramen ovale and the risk of ischemic stroke in a multiethnic population. J Am Coll Cardiol. 2007;49:797–802
  14. Meissner I, Khandheria BK, Heit JA, et al. Patent foramen ovale: innocent or guilty? (Evidence from a prospective population based study). J Am Coll Cardiol. 2006;47:440–445
  15. Petty GW, Khandheria BK, Meissner I, et al. Population-based study of the relationship between patent foramen ovale and cerebrovascular events. Mayo Clin Proc. 2006;81:602–608
  16. Hagen PT, Scholz DG, Edwards WP. Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin Proc. 1984;59:17–20
  17. Overell JR, Bone I, Lees KR. Interatrial septal abnormalities and stroke—a meta-analysis of case-control studies. Neurology. 2000;55:1172–1179
  18. Heart Disease and Stroke Statistics 2003 update. Dallas, TX: American Heart Association.
  19. Horton SC, Bunch TJ. Patent foramen ovale and stroke. Mayo Clin Proc. 2004;79:15–20
  20. Meissner I, Whisnant JP, Khandheria BK, et al. Prevalence of potential risk factors for stroke assessed by transesophageal echocardiography and carotid ultrasonography: the SPARC study stroke prevention: assessment of risk in a community. Mayo Clin Proc. 1999;74:862–869
  21. Agmon Y, Khandheria BK, Meissner I, et al. Comparison of frequency of patent foramen ovale by transesophageal echocardiography in patients with cerebral ischemic events versus in subjects in the general population. Am J Cardiol. 2001;88:330–332
  22. Lechat P, Mas JL, Lascault G, et al. Prevalence of patent foramen ovale in patients with stroke. N Engl J Med. 1988;318:1148–1152
  23. Homma S, Di Tullio MR, Sacco RL, et al. Characteristics of patent foramen ovale associated with cryptogenic stroke (A biplane transesophageal echocardiographic study). Stroke. 1994;25:582–586
  24. Foster P, Boriek AM, Butler BD, et al. Patent foramen ovale and paradoxical systemic embolism: a bibliographic review. Aviat Space Environ Med. 2003;74(suppl S):B1–B64
  25. Di Tullio M, Sacco RL, Gopal A, et al. Patent foramen ovale as a risk factor for cryptogenic stroke. Ann Intern Med. 1992;117:461–465
  26. Windecker S, Meier B. Patent foramen ovale and atrial septal aneurysm: when and how should they be treated?. ACC Curr J Rev. 2002;11:97–101
  27. Mas JL, Arquizan C, Lamy C, et al. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm or both. N Engl J Med. 2001;345:1740–1746
  28. Mas JL, Zuber M French Study Group. On patent foramen ovale and atrial septal aneurysm (Recurrent cerebrovascular events in patients with patent foramen ovale, atrial septal aneurysm, or both and cryptogenic stroke or transient ischemic attack). Am Heart J. 1995;130:1083–1088
  29. Agmon Y, Khandheria BK, Meissner I, et al. Frequency of atrial septal aneurysms in patients with cerebral ischemic events. Circulation. 1999;99:1942–1944
  30. Handke M, Harloff A, Olschewski M, et al. Patent foramen ovale and cryptogenic stroke in older patients. N Engl J Med. 2007;357:2262–2268
  31. Wilmshurst PT, Nightingale S, Walsh KP, et al. Effect on migraine of closure of cardiac right-to-left shunts to prevent recurrence of decompression illness or stroke or for haemodynamic reasons. Lancet. 2000;356:1648–1651
  32. Del Sette M, Angeli S, Leandri M, et al. Migraine with aura and right-to-left shunt on transcranial Doppler: a case-control study. Cerebrovasc Dis. 1998;8:327–330
  33. Wilmhurst PT, Nightingale S, Walsh KP, et al. Effect on migraine of closure of cardiac right-to-left shunts to prevent recurrence of decompression illness or stroke or for haemodynamic reasons. Lancet. 2000;356:1648–1651
  34. Morandi E, Anzola GP, Angeli S, et al. Transcatheter closure of patent foramen ovale: a new migraine treatment?. J Int Cardiovasc. 2003;16:39–42
  35. Sztajzel R, Genoud D, Roth S, et al. Patent foramen ovale, a possible cause of symptomatic migraine: a study of 74 patients with acute ischemic stroke. Cerebrovasc Dis. 2002;13:102–106
  36. Dubiel M, Bruch L, Schmehl I, et al. Migraine headache relief after percutaneous transcatheter closure of interartrial communications. J Interven Cardiol. 2008;21:32–37
  37. Silberstein S. Oral presentation. TCT. 2008;
  38. Silberstein S. Recent developments in migraine. Lancet. 2008;372:1369–1371
  39. Cantais EP, Louge P, Suppini A, et al. Right-to-left shunt and risk of decompression illness with cochleovestibular and cerebral symptoms in divers: Case control study in 101 consecutive dive accidents. Crit Care Med. 2003;31:84–88
  40. Walsh KP, Wilmshurst PT, Morrison WL. Transcatheter closure of patent foramen ovale using the Amplatzer septal occluder to prevent recurrence of neurological decompression illness in divers. Heart. 1999;81:257–261
  41. Homma S, Sacco RL, Di Tullio MR, et al. Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in cryptogenic stroke study. Circulation. 2002;105:2625–2631
  42. Mohr JP, Thompson JLP, Lazar RM, et al. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N Engl J Med. 2001;345:1444–1451
  43. Bogousslavsky J, Garazi S, Jeanrenaud X, et al. Lausanne Stroke with Paradoxical Embolism Study Group (Stroke recurrence in patients with patent foramen ovale: the Lausanne study). Neurology. 1996;46:1301–1305
  44. Onorato E, Melzi G, Casilli F, et al. Patent foramen ovale with paradoxical embolism: mid-term results of transcatheter closure in 256 patients. J Int Cardiovasc. 2003;16:43–50
  45. Comess KA, De Rook FA, Beach KW, et al. Transesophageal echocardiography and carotid ultrasound in patients with cerebral ischemia: prevalence of findings and recurrent stroke risk. J Am Coll Cardiol. 1994;23:1598–1603
  46. Khairy P, O'Donnell CP, Landzbert MJ, et al. Transcatheter closure versus medical therapy of patent foramen ovale and presumed paradoxical embolism: a systematic review. Ann Intern Med. 2003;9:753–760
  47. Windecker S, Wahl A, Chatterjee T, et al. Percutaneous closure of patent foramen ovale in patients with paradoxical embolism: long-term risk of recurrent thromboembolic events. Circulation. 2000;101:893–898
  48. Wahl A, Meier B, Maxel B, et al. Prognosis after percutaneous closure of patent foramen ovale for paradoxical embolism. Neurology. 2001;57:1330–1332
  49. Dearani JA, Ugurlu BS, Danielson GK, et al. Surgical patent foramen ovale closure for prevention of paradoxical embolism-related cerebrovascular ischemic events. Circulation. 1999;100(suppl II):II171–II175
  50. Homma S, Di Tullio MR, Sacco RL, et al. Surgical closure of patent foramen ovale in cryptogenic stroke patients. Stroke. 1997;28:2376–2381
  51. Martin F, Sanchez PL, Doherty E, et al. Percutaneous transcatheter closure of patent foramen ovale in patients with paradoxical embolism. Circulation. 2002;106(9):1121–1126
  52. Caes FL, Van Belleghem YV, Missault LH, et al. Surgical treatment of impending paradoxical embolism through patent foramen ovale. Ann Thorac Surg. 1995;59:1559–1561
  53. Hung J, Landzberg MJ, Jenkins KJ, et al. Closure of patent foramen ovale for paradoxical emboli: intermediate-term risk of recurrent neurological events following transcatheter device placement. J Am Coll Cardiol. 2000;35:1311–1316
  54. Braun MU, Fassbender D, Schoen SP, et al. Transcatheter closure of patent foramen ovale in patients with cerebral ischemia. J Am Coll Cardiol. 2002;39:2019–2025
  55. Windecker S, Wahl A, Chatterjee T, et al. Percutaneous closure of PFO in patients with paradoxical embolism: long-term risk of recurrent thromboembolic events. Circulation. 2000;101:893–898
  56. Brandt RR, Neumann T, Neuzner J, et al. Transcatheter closure of atrial septal defect and patent foramen ovale in adult patients using the amplatzer occlusion device: no evidence for thrombus deposition with antiplatelet agents. J Am Soc Echocardiogr. 2002;15(10 Pt. 1):1094–1098
  57. Braun MU, Fassbender UD, Schoen SP, et al. Transcatheter closure of patent foramen ovale in patients with cerebral ischemia. J Am Coll Cardiol. 2002;39:2019–2025
  58. Bruch L, Parsi A, Grad MO, et al. Transcatheter closure of interatrial communications for secondary prevention of paradoxical embolism: Single-center experience. Circulation. 2002;105:2845–2848
  59. Deeik RK, Thomas RM, Sakiyalak P, et al. Minimal access closure of patent foramen ovale: is it also recommended for patients with paradoxical emboli?. Ann Thorac Surg. 2002;74:S1326–S1329
  60. Homma S, Di Tullio MR, Sacco RL, et al. Surgical closure of patent foramen ovale in cryptogenic stroke patients. Stroke. 1997;28:2376–2381
  61. Devuyst G, Bogousslavsky J, Ruchat P, et al. Prognosis after stroke followed by surgical closure of patent foramen ovale: a prospective follow-up study with brain MRI and simultaneous transesophageal and transcranial Doppler ultrasound. Neurology. 1996;47:1162–1166
  62. Wahl A, Windecker S, Eberli FR, et al. Percutaneous closure of patent foramen ovale in symptomatic patients. J Int Cardiovasc. 2001;14:203–209
  63. Windecker S, Wahl A, Chatterjee T, et al. Percutaneous closure of patent foramen ovale in patients with paradoxical embolism: long-term risk of recurrent thromboembolic events. Circulation. 2000;101:893–898
  64. Meier B, Lock JE. Contemporary management of patent foramen ovale. Circulation. 2003;107:5–9
  65. Beitzke A, Schuchlenz H, Gamillscheg A, et al. Catheter closure of the persistent foramen ovale: mid-term results in 162 patients. J Int Cardiovasc. 2001;14:223–229
  66. Hijazi Z, Wang Z, Cao Q, et al. Transcatheter closure of atrial septal defects and patent foramen ovale under intracardiac echocardiographic guidance: Feasibility and comparison with transesophageal echocardiography. Cath Cardiovasc Int. 2001;52:194–199
  67. Bartel T, Konorza T, Arjumand J, et al. Intracardiac echocardiography is superior to conventional monitoring for guiding device closure of interatrial communications. Circulation. 2003;107:795–797
  68. Earing MG, Cabalka AK, Seward JB, et al. Intracardiac echocardiographic guidance during transcatheter device closure of atrial septal defect and patent foramen ovale. Mayo Clin Proc. 2004;79:24–34
  69. Ruiz CE, Alboliras ET, Pophal SG. The puncture technique: a new method for transcatheter closure of patent foramen ovale. Cathet Cardiovasc Intervent. 2001;53:369–372
  70. Spies C, Reissmann U, Timmermanns I, et al. Comparison of contemporary devices used for transcatheter patent foramen ovale closure. J Invasive Cardiol. 2008;20:442–447
  71. Sievert H, Horvath K, Zadan E, et al. Patent foramen ovale closure in patients with transient ischemia attack/stroke. J Int Cardiovasc. 2001;14:261–266
  72. Khositseth A, Cabalka AK, Sweeney JP, et al. Transcatheter device closure of atrial septal defect/patent foramen ovale in patients with presumed paradoxical embolism. Cathet Cardiovasc Interven. 2003;59(D-28):150
  73. Jesurum JT, Fuller CJ, Kim CJ, et al. Frequency of migraine headache relief following patent foramen ovale “closure” despite residual right to left shunt. Am J Cardiol. 2008;102:916–920
  74. Nkomo VT, Theuma P, Maniu CV, et al. Patent foramen ovale transcatheter closure device thrombosis. Mayo Clin Proc. 2001;76:1057–1061
  75. Spies C, Khandelival A, Timmermanns I, et al. Recurrent events following patent foramen ovale closure in patients alive 55 years of age with presumed paradoxical embolism. Cathet Cardiovasc Interven. 2008;72:966–970
  76. Wahl A, Kunz M, Moschovitis A, et al. Long-term results after fluoroscopic guided closure of patent foramen ovale for secondary prevention of paradoxical embolism. Heart. 2000;94:336–341
  77. Slavin L, Tobis JM, Rangarian K. Five-year experience with percutaneous closure of patent foramen ovale. Am J Cardiol. 2007;99:1316–1320
  78. Braun M, Gliech V, Boscheri A, et al. Transcatheter closure of patent foramen ovale (PFO) in patients with paradoxical embolism. Eur Heart J. 2004;25:424–430
  79. Lange SA, Schoen SP, Braun MU, et al. Perforation of aortic root as secondary complication after implantation of patent foramen ovale occlusion device in a 31-year-old woman. J Interven Cardiol. 2006;19:166–169
  80. Trepels T, Zeplin H, Sievert H, et al. Cardiac perforation following transcatheter PFO closure. Catheter Cardiovasc Interv. 2003;58:111–113
  81. Ourania Preventza O, Sampath-Kumar S, Wasnick J, et al. Late cardiac perforation following transcatheter atrial septal defect closure. Ann Thorac Surg. 2004;77:1435–1437
  82. Vojacek J, Mates M, Popelova J, et al. Perforation of the right atrium and the ascending aorta following percutaneous transcatheter atrial septal defect closure (Case report—congenital). Interact Cardiovasc Thorac Surg. 2005;4:157–159
  83. Schoen SP, Boscheri A, Lange SA, et al. Incidence of aortic valve regurgitation and outcome after percutaneous closure of atrial septal defects and patient foramen ovale. Heart. 2008;94:844–847

 Drs Holmes and Cohen have indicated they have no conflicts of interest to disclose with this article. Dr Ruiz is a proctor for AGA and for NMT.

PII: S0146-2806(09)00084-X

doi: 10.1016/j.cpcardiol.2009.06.001

Current Problems in Cardiology
Volume 34, Issue 10 , Pages 483-530 , October 2009

Article Tools

* Image Usage & Resolution